Therapeutic agent for asthma containing IL-6 inhibitor
AssigneeMotokazu Kato
InventorMotokazu Kato
Life of this patent
Estimating the term…
Abstract
The present invention provides therapeutic agents for treating human asthma through administration of an IL-6 inhibitor to humans. Representative IL-6 inhibitors in the present invention include IL-6 receptor antibodies and IL-6 antibodies. Therapeutic agents of the present invention can yield therapeutic effects in severe asthma patients who need administration of high-dose steroids and such for alleviation of symptoms, or even in patients whose symptoms are difficult to control by common treatment.
Claims9
A method for treating human severe non-eosinophilic asthma, comprising administering 162 mg of an anti-IL-6 receptor antibody to a human adult subject in need thereof, wherein the anti-IL-6 receptor antibody is tocilizumab.
Dependencies are inferred from the claim text.